Skip to main content

Ibrexafungerp Tablets Shortage

Last Updated: March 3, 2025
Status: Current

Products Affected - Description
    • Brexafemme oral tablet, Scynexis, 150 mg, unit-dose blister pack, 4 count, NDC 75788-0115-04
Reason for the Shortage
    • Scynexis recalled Brexafemme tablets in September 2023 due to a potential for cross-contamination. Additional information about the recall can be found at https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/scynexis-issues-voluntary-nationwide-recall-brexafemmer-ibrexafungerp-tablets-due-potential-cross#:~:text=The%20affected%20BREXAFEMME%C2%AE%20lots,US%2C%20beginning%20in%20December%202022.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Scynexis has Brexafemme temporarily unavailable and the company cannot estimate when the product will return to the market.

Updated

Updated March 3, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created December 3, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.